Rajagopalan LAKSHMİ, Ranjani RAMACHANDRAN, Syam SUNDAR, Baskaran M, Thiyagarajan V, Vanaja KUMAR, Anandan M

Ethionamide depolama sıcaklığının duyarlılık testine etkisi

Amaç: Ethionamide ısıya duyarlı yapısı nedeniyle, ilaç duyarlılık testinde (DST) ısının etkisini ve sıvı veya katı ortamdaki dayanıklılık durumunun araştırılması amaçlanmıştır. Yöntemler: Ethionamide çalışma solüsyonu ve Lowenstein-Jensen (LJ) besiyeri hazırlanarak 4°C ve 37°C bekletildi ve ardından DST yöntemiyle 4 haftaya kadar MGIT 960 besiyeri ile test edildi. Bulgular: Ethionamide çalışma solusyonunda 37°C'de 3 haftalık inkübasyonun ardından bozunma olduğu gözlenmiştir. Ethionamide LJ ortamında beş haftaya kadar etkinliğinde bozulma olmadan saklanabilir. Fakat 37°C de bir hafta daha bekletilmesi ilaç duyarlılık profiline zararlı etkili olabilir. Ethionamide 37°C bekletilmesiyle farklı zaman aralıklarında sıvı ya da LJ ortamında bekletilmesiyle etkinliğinde değişmeler olduğu saptandı. Sonuç: DST ortamında ethionamide için iki haftaya kadar olan testlerin değerlendirilmesi önerilir.

Effect of temperature on storage of ethionamide during susceptibility testing

Objective: Ethionamide being thermolabile in nature, effect of temperature on the drug and its stability in liquid and solid media during susceptibility testing procedures was assessed to understand the inconsistency in DST formats. Methods: Working solution of ethionamide and Lowenstein- Jensen (LJ) media incorporated with ethionamide were preincubated at 4°C and 37°C prior to DST methods was incubated till 4 weeks at different temperatures and utilized for DST in MGIT 960. Results: Degradation of ethionamide working solution was observed at 37°C after 3 weeks of incubation. Ethionamide incorporated LJ media can be stored without compromise on susceptibility up to 5 weeks. But, a week of prior incubation at 37°C has deleterious effect on the DST profile. Ethionamide was found to degrade at 37°C after different time points when stored as solution or as LJ media. Conclusion: Use of DST formats that provide results within 2 weeks can be recommended for ethionamide susceptibility testing. J Microbiol Infect Dis 2013; 3(3): 128-132

PDF

___

1. Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 2005;25:564-569.
2. Lakshmi R, Vanaja Kumar, Fathima Rahman, Ranjani Ramachandran. Consistency - a prime quality control for standard laboratory strain Mycobacterium tuberculosis H37Rv especially with ethionamide susceptibility testing. Ind J Med Res 2012;135:672-674.
3. Bennetto CJ, King JR, Turner ML, et al. Effects of concentration and temperature on the stability of nevirapine in whole blood and serum. Clin Chem 2004; 50:209-211.
4. Yu X, Jiang G, Li H, et al. Rifampin Stability in 7H9 Broth and Lowenstein-Jensen Medium. J Clin Microbiol 2011;49:784- 789.
5. Griffith ME, Bodily HL. Stability of Antimycobacterial Drugs in Susceptibility Testing. Antimicrobial Agents and Chemotherapy 1992;36:2398-2402.
6. Shishoo CJ, Shah SA, Rathod IS, et al. 1999. Stability of rifampicin in dissolution medium in presence of isoniazid. Int J Pharm 1999;190:109-123.
7. Ali J, Ali N, Sultana Y, et al. Development and validation of a stability-indicating HPTLC method for analysis of antitubercular drugs. Acta Chromatographica 2007; 18:168-179.
8. Peloquin CA, Durbin D, Childs J, et al. Stability of Antituberculosis Drugs Mixed in Food. CID 2007;45:521.
9. Sigma- Aldrich - product Information - Streptomycin Sulfate Sigma Prod. No. S6501 Page 1 - 3 08/01/97 - CKV. Avalaible at www.sigma-aldrich.com.
10. Find Diagnositics.org [Homepage on the internet]. MGIT Procedure Manual for BACTEC(TM) MGIT 960(TM) TB System (Also applicable for Manual MGIT) Mycobacteria Growth Indicator Tube (MGIT) Culture and Drug Susceptibility Demonstration Projects by Dr. Salman Siddiqi and Dr. Sabine RüschGerdes. 2006; [Available at: http://www.finddiagnostics.org/resource-centre/reports_brochures/071130_mgit_manual.html].
11. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ 1969;41:21-43.
12. Standard Operating Protocol for Mycobacteriology laboratory. Version1.0 June 2010. Available at: http://www.trc-chennai.org/pdf/sop.pdf.
13. Martin A, von Groll A, Fissette K, et al. Rapid Detection of Mycobacterium tuberculosis Resistance to Second-Line Drugs by Use of the Manual Mycobacterium Growth Indicator Tube System. J Clin Microbial 2008;46:3952-3956.
14. Larsen MH, Vilcheze C, Kremer L, et al. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Molecular Microbiology 2002;46:453-466.
15. Morlock GP, Metchock B, Sikes D, et al. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy 2003;47:3799-3805.
16. Wang XD, Gu J, Wang T, et al. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation. Molecular Microbiology 2011;82:1375-1391.
17. Mitchison DA. Drug resistance in tuberculosis. Eur Respir J 2005;25:376-379.
18. Jha NS, Kishore N. Binding of streptomycin with bovine serum albumin: Energetics and conformational aspects. Thermochimica Acta 2009;482:21-29.